Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.

Georgios PonirakisMuhammad A Abdul-GhaniAmin JayyousiHamad AlmuhannadiIoannis N PetropoulosAdnan KhanHoda GadOsama MigahidAyman MegahedRalph DeFronzoZiyad MahfoudMona HassanHanadi Al HamadMarwan RamadanUazman AlamRayaz Ahmed Malik

Published in: BMJ open diabetes research & care (2021)

Treatment with exenatide and pioglitazone or basal-bolus insulin results in corneal nerve regeneration, but no change in neuropathic symptoms or sudomotor function over 1 year.

Keyphrases

type diabetes
stem cells
wound healing
glycemic control
combination therapy
physical activity
replacement therapy